IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Recent Updates on Diagnosis, Treatment and Challenges of COVID-19: A Review

Author: ANKIT SHARMA, AVIJIT MAZUMDER, SAUMYA DAS, ANAMIKA SHARMA, SUNITI CHAND
Abstract: A novel COVID-19, designated as extreme Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2), was first identified in Wuhan, China in December 2019, triggering COVID-19, a highly infectious disease. As of August 26, 2020, COVID-19 has now spread globally to become a global pandemic affecting more than 24 million people, taking the lives of more than 800,000 people worldwide. For certain people, COVID-19 is asymptomatic and it can cause symptoms ranging from flu-like to acute respiratory distress syndrome (ARDS), pneumonia and death for others. While an effective vaccine to protect against COVID-19 is supposed to be available, the world currently relies on social distancing and hygiene initiatives and repurposed medicines. Different body systems have been shown to have significant adverse effects: the immune system (including, but not limited to, Guillain-Barré syndrome and pediatric multisystem inflammatory syndrome), the respiratory system (lung fibrosis and pulmonary thromboembolism), the cardiovascular system (cardiomyopathy and coagulopathy), the nervous system (sensory dysfunction and stroke) and the skin and gastrointestinal system. Mental wellbeing was also found to be adversely affected in COVID-19 patients. It is possible that the cost of caring for survivors of COVID-19 is high. The COVID-19 pandemic poses an unprecedented global challenge that has been addressed by the rapid development of pharmacological research and clinical trials with a remarkable response. As are the possible therapeutic agents, the infection rates of COVID-19 are constantly evolving. Management is currently focused on case identification and control, prevention of infections, and compassionate treatment. In this review, the recent updates of diagnosis, treatment and challenges of COVID- 19 will be discussed.
Keyword: COVID Respiratory Syndrome, pneumonia, pandemic, diagnosis, adverse effects, management.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.187
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free